scholarly journals Evaluation of effect of brainstem evoked response audiometry in hyperlipidemic patients

Author(s):  
Shivakumar Senniappan ◽  
Gowri Paramasivam

<p class="abstract"><strong>Background:</strong> Brain stem evoked response audiometry (BERA) is a useful objective assessment of hearing. The major advantage of this procedure is its ability to test even infants in whom conventional audiometry may not be useful. This investigation can be used as a screening test for deafness at high risk. This study is to correlate changes in brainstem evoked response audiometry parameters concerning lipid profile.</p><p class="abstract"><strong>Methods:</strong> The study was conducted between January 2019 to June 2020 on 50 patients attending ENT OPD in Vinayaka Mission’s Kirupanandha Variyar Medical College and Hospital, Salem. All patients with auditory and/or vestibular complaints were seen at the otorhinolaryngology OPD and underwent an otorhinolaryngological examination, audiological studies (pure tone audiometry) and an electrophysiological assessment BERA.  </p><p class="abstract"><strong>Results:</strong> The results of BERA was considered. A total of 5 waveforms and 3 interpeak latency waves were calculated. It was recorded from both the ears. There was a significant increase in the values of absolute waves II, III, IV, and V and interpeak latency wave values I-II and I-V.</p><p class="abstract"><strong>Conclusions:</strong> Early identification of hyperlipidemic patients is useful in preventing disease progression and associated morbidity and mortality. BERA is a non-invasive method which can help us to detect central auditory pathway dysfunction at early stages in hyperlipidemic patients even before the patient's experience symptomatic hearing loss.</p>

2021 ◽  
Vol 29 (2) ◽  
pp. 182-188
Author(s):  
Deepika Goswami ◽  
Saurabh Srivastava ◽  
Anuja Bhargava ◽  
Syed M Faiz ◽  
Zeba Siddiqi ◽  
...  

Introduction Diabetes has become a global epidemic. Hearing loss has been long associated with diabetes. Brainstem Evoked Response Audiometry (BERA) is an objective, non-invasive, electro diagnostic test that not only evaluates the functional integrity of the subcortical auditory pathway but also provides topo-diagnosis of hearing loss. This study aims to identify the role BERA in detecting hearing loss early in diabetic patients.Materials and Methods In this study a total of 210 patients were taken and subjected to blood glucose levels followed by PTA were divided into two groups. Group I (n=105) consisted of diabetic patients with sensorineural hearing loss (SNHL) and Group II (n=105) had age and sex matched non-diabetics with SNHL. All the patients were evaluated with BERA.Results All the patients were subjected to Brain Stem Evoked Response Audiometry (BERA). Absolute latency of Wave I, III, V, I-III, III-V and I-V were assessed for both the ears. In both ear Absolute latency were significantly higher in diabetics as compared to non-diabetic patientsConclusion The findings of present study showed that the severity of hearing loss was significantly higher in diabetic patients as compared to non-diabetic controls. Level of glycemic control showed a possible link with severity of hearing loss.


2017 ◽  
Vol VOLUME 5 (VOLUME 5 NUMBER 2 JULY 2017) ◽  
pp. 11-14
Author(s):  
Ankur Wats

INTRODUCTION: The Prevalence of Diabetes Melilites Is Increasing All Over the World Particularly in The Developing Countries. Diabetes Is Associated with Hearing Impairment Which Has Been Described as Sensorineural in Origin, But Evidence Favoring a Specific Mechanism Is Insufficient. Brainstem Evoked Response Audiometry Is a Simple, Non-Invasive Procedure to Detect Early Impairment of Acoustic Nerve and Auditory Pathway, Even in The Absence of Specific Symptoms. The Present Study Is Under Taken to Evaluate the Impact of Type 2 Diabetes Mellitus on BERA Parameters. OBJECTIVES: To Analyze and Compare the Brainstem Evoked Response Audiometry in Diabetic Patients and Age and Gender Matched Controls. METHODS: 40 Type 2 Diabetic Patients Attending Outpatient Department of Otorhinolaryngology and Medicine, C. S. S. Hospital, Meerut and 40 Non Diabetic Age and Gender Matched Subjects from General Population Were Selected Randomly, With None of Them Having Complains of Hearing Loss and Were Subjected to Brainstem Evoked Response Audiometry (BERA). BERA Parameters Such as Latency of Wave I, II, III, IV, And V; Inter-Peak Latencies I-III, I-V and III-V Were Analyzed. BERA Parameters Were also assessed according to The Duration of Diabetes and Fasting Blood Glucose Levels. RESULTS: Patients with Type 2 Diabetes Mellitus Were Found to Have Subclinical Hearing Impairment as Revealed by Impaired Auditory Brainstem Response. In This Study Diabetic Patients Showed a Statistically Significant (p value<0.05) Delay in The Latency of Waves I, III and V and Inter-Peak Latency of Waves I-III, I-V and III-V When Compared to Controls. There Was a Positive Correlation Between Prolongation of Latencies and Duration of Diabetes Mellitus. The Latencies Were Also Found to Be Prolonged with altered blood glucose levels. CONCLUSION: The present study correlates with earlier findings that impaired BERA response in diabetic patients is a consequence of microangiopathy. Meticulous control of blood sugar levels is a must to prevent the early complications of diabetes, so that further damage to auditory pathway can be prevented. KEY-WORDS: Diabetes mellitus; Hearing; Brainstem evoked response audiometry (BERA).


1992 ◽  
Vol 106 (10) ◽  
pp. 887-892 ◽  
Author(s):  
S. K. Lau ◽  
W. I. Wei ◽  
J. S. T. Sham ◽  
D. T. K. Choy ◽  
Y. Hui

AbstractA prospective study of the effect of radiotherapy for nasopharyngeal carcinoma on hearing was carried out on 49 patients who had pure tone, impedance audiometry and auditory brain stem evoked response (ABR) recordings before, immediately, three, six and 12 months after radiotherapy. Fourteen patients complained of intermittent tinnitus after radiotherapy. We found that 11 initially normal ears of nine patients developed a middle ear effusion, three to six months after radiotherapy. There was mixed sensorineural and conductive hearing impairment after radiotherapy. Persistent impairment of ABR was detected immediately after completion of radiotherapy. The waves I–III and I–V interpeak latency intervals were significantly prolonged one year after radiotherapy. The study shows that radiotherapy for nasopharyngeal carcinoma impairs hearing by acting on the middle ear, the cochlea and the brain stem auditory pathway.


Author(s):  
Shanthimalar R. ◽  
Muthuchitra S. ◽  
Mary Nirmala S. ◽  
Udhaya Chandrika G. ◽  
Mohamed Rasith H.

<p><strong>Background: </strong>Diabetes mellitus (DM) which is prevalent in world is associated with sensorineural hearing loss. Brainstem evoked response audiometry (BERA) is a simple, non-invasive procedure to detect early impairment of acoustic nerve and auditory pathway. The present study is under taken to evaluate the impact of DM on BERA parameters. Aim of the study was to compare the BERA of diabetic patients to those of age and gender matched controls to assess the involvement of central auditory pathway.</p><p><strong>Methods</strong>: A cross sectional study was conducted on 35 diabetic patients, aged 35 to 55 years, who were on treatment for at least 2 years, and 35 age and sex matched control participants, were subjected for BERA at 70,80 and 90 dB. The waveforms, absolute latency of wave I, wave III, wave V and interwave/ inter peak latency of I-III, III-V and I-V were analyzed with respect to both groups.</p><p><strong>Results</strong>: The absolute latency of wave III and wave V, interpeak/ interwave latency of I-III, interpeak/ interwave latency of I-V, III-V and absolute latency of wave V were highly significant at corresponding tested stimuli in the diabetic group compared to the control group.</p><p><strong>Conclusions</strong>: Early involvement of central auditory pathway in diabetic patients, can be detected with fair accuracy with auditory evoked potential studies; if done on a regular basis warrants meticulous glycemic control and prevents further damage.</p>


Author(s):  
Manish Munjal ◽  
Karanpreet Singh ◽  
Parth Chopra ◽  
Shubham Munjal ◽  
Hemant Chopra ◽  
...  

<p class="abstract"><strong>Background:</strong> The effect of electrolyte imbalance on hearing thresholds and its objective manifestation, as delayed latencies or inter-peak intervals in evoked response audiometry is studied.</p><p class="abstract"><strong>Methods:</strong> The present prospective study was undertaken in a period of one and a half years, to analyze the audiological profile in patients of chronic renal failure and renal allograft recipients. 60 patients were randomly selected from the out- patient and indoor services of nephrology, urology and oto-rhino-laryngology, Dayanand Medical College and Hospital, Ludhiana. Brain stem evoked response audiometry was performed and the latencies were tabulated.  </p><p class="abstract"><strong>Results:</strong> A significant delay in the absolute latency of wave V was noted in hyponatremic patients of CRF on comparison with patients of CRF having a normal serum Na<sup>+</sup> levels. The I-V interpeak interval was also seen to be significantly delayed on comparison. A statistically significant delayed I-III inter-peak latency was also observed in hypernatremic patients in comparison to patients having a serum Na<sup>+</sup> level in the normal range. No significance of serum creatinine levels and wave latencies was noted on comparison between the three categories of patients of CRF as categorized by their serum creatinine levels.</p><p class="abstract"><strong>Conclusions:</strong> There is a definite deterioration of the audiological function in patients of chronic kidney disease, and some reversal of these abnormalities following a successful renal transplantation; indirectly pointing towards uremic milieu being the culprit.</p>


Author(s):  
Hemal Shah ◽  
Pramod Kharadi ◽  
Krunal Patel ◽  
Sushil Jha ◽  
Abhishek Kumar Singh

<p class="abstract"><strong>Background:</strong> Brainstem evoked response audiometry (BERA) is most specific and sensitive test for brain stem dysfunction. It is most important objective method for evaluating peripheral auditory system in neonates, infants, sedated and comatose patients and other person who doesn’t understand the language. Objective of the study was to evaluate correlation BERA with other audiological tests in different types of hearing loss as well as to study variations of wave forms in different types of hearing loss.</p><p class="abstract"><strong>Methods:</strong> Patients underwent a complete ENT check up to rule out any actively discharging gears, wax, infection or any middle ear problems. Different audiometric tests: pure tone audiometry (PTA), distortion product otoacoustic emissions, auditory steady-state response (ASSR) and BERA were applied to the patients.  </p><p class="abstract"><strong>Results:</strong> The majority of the patients (32 cases) belonged to the age group of 0-5 years. Maximum cases were of sensorineural hearing loss (60%). ASSR was highly sensitive (85.1%) for estimation of hearing threshold and specificity was 100% (p&lt;0.001). BERA was also highly significant for estimation of hearing threshold (sensitivity: 83%; specificity: 92.3%; p value &lt;0.001).</p><p class="abstract"><strong>Conclusions:</strong> BERA has high degree of accuracy in detecting hearing threshold as an objective test but not as much accurate as ASSR. It is more valuable in terms of identification of site and size of the lesion in auditory pathway and identification for the type of the deafness.</p>


2020 ◽  
Vol 34 (3) ◽  
pp. 109-117
Author(s):  
Aparna Aradhana ◽  
Gadadhar Sarangi ◽  
Prasant Saboth ◽  
Radha Tripathy

Objectives: To find out the incidence of hearing impairment in Neonatal Intensive Care Unit (NICU)-admitted newborns and to correlate between several risk factors. Design: Prospective observational study. Setting: In a tertiary teaching hospital of Odisha between October 2014 and October 2016. Study population: 100 newborns delivered in the institution and admitted in NICU with usual indications and risk factors that underwent otoacoustic emission 1 and 2 (OAE1, OAE2) and Brainstem Evoked Response Audiometry (BERA). Results: 84 babies in OAE1 and 86 babies in OAE2 got “pass” results. In BERA test, 92 babies got normal waveform. 7 (13.7%) of 51 premature babies, 5 (38.5%) of 13 very low birth weight babies, 7 (17.5%) of 40 babies receiving ototoxic medication for >5 days, 7 (31.8%) of 22 babies with hyperbilirubinemia, 6 (42.9%) of 14 babies with sepsis, 5 (20%) of 20 babies with birth asphyxia, 3 (60%) of 5 babies under mechanical ventilation for >5 days, 1 baby with ear abnormality, and 1 (50%) out of 2 babies with congenital infections had hearing impairment and statistically significant association with abnormal OAE and BERA test. Conclusion: There is high incidence of hearing loss in NICU-admitted newborns. OAE and BERA both should be performed for complete evaluation of hearing. Important risk factors are elaborated. Predischarge hearing assessment in NICU is most important.


Sign in / Sign up

Export Citation Format

Share Document